Search Results 291-300 of 18003 for Alopecia
... alopecia - Patients who are receiving any other investigational agents - Patients with uncontrolled intercurrent illness - Patients who cannot discontinue ...
Alopecia After Switch to Tenofovir Alafenamide in 6 African American Women. Open Forum Infect Dis. 2019 Jul; 6(7):ofz278. Epub 2019 Jun 06. View PubMed ...
* Persistent toxicities caused by previous anti-cancer therapy excluding alopecia, not yet improved to Grade ≤ 1 or baseline. * Clinically meaningful ...
Biopsy proven diagnosis of Fontal Fibrosing Alopecia (a clinical variant of LPP restricted to frontal scalp); Good general health as confirmed by medical ...
Natural History Evaluation Among Female Breast Cancer Survivors with Endocrine Therapy-Induced Alopecia. Rochester, Minn., Mankato, Minn., Albert Lea, Minn ...
- All grades of alopecia are acceptable - Endocrine dysfunction on replacement therapy is acceptable - Severe or unstable medical condition, including ...
... Alopecia areata, Melasma. Show more areas of focus for Ashley B. Wentworth, M.D.. Josh P. Wiedermann, M.D.. Otolaryngologist. Rochester ...
... alopecia or laboratory abnormalities otherwise meeting eligibility requirements * Received prior chemotherapeutic, investigational, or other therapies for ...
... alopecia, bone marrow and organ functions); Patient has impairment of gastrointestinal (GI) function or GI disease that may significantly alter the ...
... alopecia, and hypothyroidism that is controlled with hormone replacement therapy). Active, known, or suspected autoimmune disease. Note: Patients with type ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.